Initial characterization and autoradiographic localization of a novel sigma/opioid binding site in immune tissues

Journal of Neuroimmunology

Volumn 67, Issue 2, 1996, Pages 83-96

  Whitlock, Ben B ^a   Liu, Yuhong ^a   Chang, Susie ^b   Saini, Priya ^c   Ha, Byeong Keun ^a   Barrett, Thomas W ^a   Wolfe Jr , Seth A ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Dopamine; Human; Immune; Leukocyte; Naltrexone; Opioid; Pentazocine; Rat; Receptor, 3 PPP; Sigma; Spleen

Indexed keywords

CLORGYLINE; DEXTROMETHORPHAN; DEXTRORPHAN; HALOPERIDOL; N ALLYLNORMETAZOCINE; NALTREXONE; OPIATE; PENTAZOCINE; PHOSPHOLIPASE C; PRECLAMOL; PROADIFEN; SELEGILINE; SIGMA OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; FEMALE; IMMUNOMODULATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

EID: 0030199759     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00041-0     Document Type: Article

References (63)

1. Bidlack, J.M., Saripalli, L.D. and Lawrence, D.M.P. (1992) κ-opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol. 227, 257-265.
2. Booth, R.G., Wyrick, S.D., Baldessarini, R.J., Kula, N.S., Myers, A.M. and Mailman, R.B. (1993) New σ-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies. Mol. Pharmacol. 44, 1232-1239.
3. 3H]-(+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors. Mol. Neuropharmacol. 3, 117-126.
4. Bowen, W.D., Hellewell, S.B. and McGarry, K.A. (1989) Evidence for a multi-site model of the rat brain σ receptor. Eur. J. Pharmacol. 163, 309-318.
5. Bylund, D.B. and Yamamura, H.I. (1990) Methods for receptor binding. In: eds. H.I. Yamamura, S.J. Enna and M.J. Kuhar, Methods in Neurotransmitter Receptor Analysis, Raven Press, New York, pp. 1-35.
6. 3H](+)-pentazocine binding sites on cells of the immune system. J. Neuroimmunol. 35, 153-166.
7. Carr, D.J.J., de Costa, B.R., Kim, C.-H., Jacobson, A.E., Guarcello, V., Rice, K.C. and Blalock, J.E. (1989) Opioid receptors on cells of the immune system: evidence for δ- and κ-classes. J. Endocrinol. 122. 161-168.
8. Carr, D.J.J., Mayo, S., Woolley, T.W. and de Costa, B.R. (1992) Immunoregulatory properties of (+)-pentazocine and sigma ligands. Immunology 77, 527-531.
9. Casellas, P., Bourrié, B., Canat, X., Carayon, P., Buisson, I., Paul, R., Brelière, J.C. and Le Fur, G. (1994) Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses. J. Neuroimmunol. 52, 193-203.
10. Chen, J.C., Smith, E.R., Cahill, M., Cohen, R. and Fishman, J.B. (1993) The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52, 389-396.
11. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
12. 3H]TCP. Neurosci. Lett. 67, 101-106.
13. Garza Jr., H.H., Mayo, S., Bowen, W.D., de Costa, B. and Carr, D.J.J. (1993) Characterization of a (+)-azidophenazocine-sensitive sigma receptor on splenic lymphocytes. J. Immunol. 151, 4672-4680.
14. 3H]-phencyclidine in brain membranes. Life Sci. 30, 2147-2154.
15. Hazum, E., Chang, K.-J. and Cuatrecasas, P. (1979) Specific nonopiate receptors for β-endorphin. Science 205, 1033-1035.
16. Hellewell, S-B. and Bowen, W.D. (1990) A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 527, 244-253.
17. Itzhak, Y. and Kassim, C.O. (1990) Clorgyline displays high affinity for sigma binding sites in C57BL/6 mouse brain. Eur. J. Pharmacol. 176, 107-108.
18. 3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 193, 21-27.
19. Klein, M., Cooper, T.B. and Musacchio, J.M. (1994) Effects of haloperidol and reduced haloperidol on binding to σ sites. Eur. J. Pharmacol. 254, 239-248.
20. Krug, E.L. and Kent, C. (1984) Phospholipase C from Clostridium perfringens: preparation and characterization of homogeneous enzyme. Arch. Biochem. Biophys. 231, 400-410.
21. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238, 739-748.
22. Largent, B.L., Wikström, H., Gundlach, A.L. and Snyder, S.H. (1987) Structural determinants of σ receptor affinity. Mol. Pharmacol. 32, 772-784.
23. Liu Y., Whitlock, B.B., Pultz, J.A. and Wolfe Jr., S.A. (1995) Sigma-1 receptors modulate functional activity of rat splenocyles. J. Neuroimmunol. 59, 143-154.
24. Liu, Y. and Wolfe Jr., S.A. (1996) Haloperidol and spiperone potentiate murine splenic B cell proliferation. Immunopharmacol., in press.
25. Lowry, O.H., Rosenhrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
26. Makman, M.H., Bilfinger, T.V. and Stefano, G.B. (1995) Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154, 1323-1330.
27. 3-opiate receptors. Eur. J. Pharmacol. 273, R5-R6.
28. Marks, M.J. and Medzihradsky, F. (1974) Characterization of the transport system for benzomorphans in leukocytes. Mol. Pharmacol. 10, 837-848.
29. Martin, W.R., Eades, C.G., Thompson, J.A., Hoppler, R.E. and Gilbert, P.E. (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
30. Munson, P.J. and Rodbard, D. (1980) Ligand: a versatile approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
31. 3H]-3-(3-hydroxyphenyl)-N-(1-propyl) piperidine. Mol. Pharmacol. 35, 1-5.
32. 3 receptor. J. Med. Chem. 37, 4109-4117.
33. Ovadia, H. and Abramsky, O. (1987) Dopamine receptors on isolated membranes of rat lymphocytes. J. Neurosci. Res. 18, 70-74.
34. Ovadia, H., Nitsan, P. and Abramsky, O. (1989) Characterization of opiate binding sites on membranes of rat lymphocytes. J. Neuroimmunol. 21, 93-102.
35. Paul, R., Lavastre, S., Floutard, D., Floutard, R., Canat, X., Casellas, P., Le Fur, G. and Brelière, J.-C. (1994) Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747. J. Neuroimmunol. 52, 183-192.
36. Quirion, R., Bowen, W.D., Itzhak, Y., Junien, J.L., Mussachio, J.M., Rothman, R.B., Su, T.-P., Tam, S.W. and Taylor, D.P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13, 85-86.
37. Quirion, R., Chicheportiche, R., Johnson, K.M., Lodge, D., Tam, S.W., Woods, J.H. and Zukin, S.R. (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci. 10, 444-446.
38. Radulescu, R.T., de Costa, B.R., Jacobson, A.E., Rice, K.C., Blalock, J.E. and Carr, D.J.J. (1991) Biochemical and functional characterization of a μ-opioid receptor binding site on cells of the immune system. Prog. Neuroendocrinimmunol. 4, 166-179.
39. 5 receptors in human peripheral blood lymphocytes: a radioligand study. J. Neuroimmunol. 53, 1-7.
40. Ross, S.B. (1991) Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450. Pharmacol. Toxicol. 68, 293-301.
41. 3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosleric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. Mol. Pharmacol. 39, 222-232.
42. 3H]Morphine binding is enhanced by IL-1 stimulated thymocyte proliferation. FEBS Lett. 287, 93-96.
43. Santambrogio, L., Lipartiti, M., Bruni, A. and Dal Toso, R. (1993) Dopamine receptors on human T- and B-lymphocytes. J. Neuroimmunol. 45, 113-119.
44. Sbinga, N.E.S. and Goldstein, A. (1988) Opioid peptides and opioid receptors in cells of the immune systems. Ann. Rev. Immunol. 6, 219-249.
45. Schweigerer, L., Schmidt, W., Teschemacher, H. and Gramsch, L. (1985) β-endorphin: surface binding and internalization in thymoma cells. Proc. Natl. Acad. Sci. USA 82, 5751-5755.
46. 3) as a target for neuroleptics. Nature 347, 146-151.
47. Stefano, G.B., Digenis, A., Spector, S., Leung, M.K., Bilfinger, T.V., Makman, M.H., Scharrer, B. and Abumrad, N.N. (1993) Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes and a role in immunosuppression. Proc. Natl. Acad. Sci. USA 90, 11099-11103.
48. 3H]SKF-10047 to etorphine-inaccessible sites in guinea pig brain. Eur. J. Pharmacol. 75, 81-82.
49. 3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. J. Pharmacol. Exp. Ther. 223, 284-290.
50. Tam, S.W. (1983) Naloxone-inaccessible σ receptor in rat central nervous system. Proc. Natl. Acad. Sci. USA 80, 6703-6707.
51. 3H]haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA 81, 5618-5621.
52. Vaupel, D.B. (1983) Naltrexone fails to antagonize the effects of PCP and SKF 10,047 in the dog. Eur. J. Pharmacol. 92, 269-274.
53. 3H]TCP: a new tool with high affinity for the PCP receptor in rat brain. Brain Res. 280, 194-197.
54. 3H](+)-pentazocine in clonal cell lines. Soc. Neurosci. Abstr. 18, 22#16.8.
55. Vilner, B.J., John. C.S. and Bowen, W.D. (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 55, 408-413.
56. Vincent, J.P., Cavey, D., Kamenka, J.M., Geneste, P. and Lazdunski, M. (1978) Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system. Brain Res. 152, 176-182.
57. Walker, J.M., Bowen, W.D., Walker, F.O., Matsumoto, R.R., de Costa, B. and Rice, K.C. (1990) Sigma receptors: biology and function. Pharmacol. Rev. 42, 355-402.
58. Walsh, K.A. (1970) Trypsinogens and trypsins of various species. In: ed. G.E. Perlmann and L. Lorand, Proteolytic Enzymes. Academic Press Inc., New York, pp. 41-59.
59. Wolfe, Jr., S.A., Culp, S.G. and De Souza, E.B. (1989) σ-Receptors in endocrine organs: identification, characterization and autoradiographic localization in rat pituitary, adrenal, testis and ovary. Endocrinology 124, 1160-1172.
60. Wolfe, Jr., S.A. and De Souza, E.B. (1992) Sigma receptors in the brain-endocrine-immune axis. In: ed. J.M. Kamenka and E.F. Domino, Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?. NPP Books, Ann Arbor, MI, pp. 927-958.
61. Wolfe, Jr., S.A. and De Souza, E.B. (1994) Role of sigma binding sites in modulation of endocrine and immune functions. In: ed. Y. Itzhak, Sigma Receptors. Academic Press Inc., San Diego, CA, pp. 287-317.
62. Wolfe, Jr., S.A., Kulsakdinun, C., Battaglia, G., Jaffe, J.J. and De Souza, E.B. (1988) Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. J. Pharmacol. Exp. Ther. 247, 1114-1119.
63. Wu, X.-Z., Bell, J.A., Spivak, C.E., London, E.D. and Su, T.-P. (1991) Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J. Pharmacol. Exp. Ther. 257, 351-359.